Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

fda_building_62

“You are not a cow” – FDA warns against using ivermectin to treat COVID

August 23, 2021 Sales and Marketing

The FDA has had to issue a warning against taking ivermectin, the anti-parasitic drug designed for livestock, to treat or …
News

COVID-19 boosters significantly lower infection risk, study in Israel finds

August 23, 2021 Sales and Marketing

A study in Israel has found that a third dose of the Pfizer COVID-19 vaccine significantly improved protection from infection …
News

Record number of children in hospital with COVID in US

August 16, 2021 Sales and Marketing

The number of children in the US who have been hospitalised with COVID-19 has hit a record high. As of …
News

All 16 and 17-year-olds in England to be offered COVID vaccine by 23 August

August 16, 2021 Sales and Marketing

The UK government has announced that all 16 and 17-year-olds will be offered their first COVID vaccine dose or the …
News

Eli Lilly’s lebrikizumab significantly improves atopic dermatitis in Phase III trial

August 16, 2021 Sales and Marketing

Eli Lilly’s lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase III trials. …
News

Health Canada accepts rolling submission for Merck’s experimental COVID therapy

August 16, 2021 Sales and Marketing

Merck has begun its rolling submission to Health Canada for its experimental antiviral agent, molnupiravir, as a potential COVID-19 therapy. …
News
pfizer

Australia buys Pfizer vaccines from Poland amid record COVID infections

August 16, 2021 Sales and Marketing

Australia has purchased around 1 million Pfizer vaccines from Poland as the country battles a wave of infections. Australian Prime …
News

Researchers develop new method to kill bacteria on medical implants

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers from Chalmers University of Technology, Sweden, have developed a new method to prevent bacterial infections relating to medical implants …
News

‘Potential’ link between vaccines and menstruation changes

August 9, 2021 Sales and Marketing

France’s health body has said changes in women’s menstrual cycles are a “potential” side effect of receiving the Moderna or …
News

Psoriasis treatment bimekizumab maintains high Levels of skin clearance

August 9, 2021 Sales and Marketing

New two-year data has shown that bimekizumab maintained high Levels of skin clearance in patients with moderate to severe plaque …
News
az

First new adult CDK treatment in 20 years gains UK and EU approval

August 9, 2021 Medical Communications, Research and Development, Sales and Marketing

AstraZeneca has announced the EU approval of Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, alongside a licence extension from …
News

FDA approves Nexviazyme as treatment for late-onset Pompe disease

August 9, 2021 Sales and Marketing

The FDA has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset …
News
az

Sierra Oncology to licence myelofibrosis candidate from AstraZeneca

August 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Under a new agreement announced on Friday, AstraZeneca will licence AZD5153, a potent and selective BRD4 BET inhibitor with a …
News

Novartis set to launch new Zolgensma trial to expand use

August 3, 2021 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novartis has announced that it will launch a new Phase III study to expand the use of Zolgensma – the …
News
img_4190-e1376666350337-web

Pulse oxygen monitors less effective on darker skin, MHRA warns

August 2, 2021 Sales and Marketing

The MHRA has warned that pulse oxygen monitors, devices designed to spot early signs of dangerous falls in oxygen levels …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026